BIOMARKER PROFILING (ERBB2, P53, AND PR) FOR STAGE I OF BREAST CANCER

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

REZAEI TAVIRANI MAJID; ZAMANIAN AZODI MONA; AZIZI JALILIAN FARID; KHODAKARIM SOHEILA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Archives of Advances in Biosciences Year:2013 | Volume:4 | Issue:4 Page(s): 47-50

Download Full-Text

View:

195

Download:

Cites:

Information Journal Paper

Title

BIOMARKER PROFILING (ERBB2, P53, AND PR) FOR STAGE I OF BREAST CANCER

Author(s)

REZAEI TAVIRANI MAJID | ZAMANIAN AZODI MONA | AZIZI JALILIAN FARID | KHODAKARIM SOHEILA | Issue Writer Certificate

Keywords

BREAST CANCER

BIOMARKER

DETECTION

STAGING

TREATMENT

Abstract

BREAST CANCER (BC) accounts for one of the major health problems around the world. Since the diagnosis process can have great effect on therapy outcomes, we studied the BIOMARKERs specific to breast tumors stage I based on examining different Iranian patients. Cases from different stages were examined to discover their highly expressed proteins. In addition, pathologic evaluations were performed as the diagnosis procedure. Considering positive percentage of over-expressed protein in different stages in the population, it is guessed that over-expression of ErBb2 and PR are positively correlated, while P53 is in negative correlation with them. Therefore, these molecules can probably account for stage I biological marker. This study suggests that alterations in over-expression of specific BIOMARKERs in different stages may be associated to the stage classification, and can help achieve more effective therapies of this malignancy.

Cites

No record.

References

No record.

Cite

APA: Copy

REZAEI TAVIRANI, MAJID, ZAMANIAN AZODI, MONA, AZIZI JALILIAN, FARID, & KHODAKARIM, SOHEILA. (2013). BIOMARKER PROFILING (ERBB2, P53, AND PR) FOR STAGE I OF BREAST CANCER. ARCHIVES OF ADVANCES IN BIOSCIENCES (JOURNAL OF PARAMEDICAL SCIENCES), 4(4), 47-50. SID. https://sid.ir/paper/315822/en

Vancouver: Copy

REZAEI TAVIRANI MAJID, ZAMANIAN AZODI MONA, AZIZI JALILIAN FARID, KHODAKARIM SOHEILA. BIOMARKER PROFILING (ERBB2, P53, AND PR) FOR STAGE I OF BREAST CANCER. ARCHIVES OF ADVANCES IN BIOSCIENCES (JOURNAL OF PARAMEDICAL SCIENCES)[Internet]. 2013;4(4):47-50. Available from: https://sid.ir/paper/315822/en

IEEE: Copy

MAJID REZAEI TAVIRANI, MONA ZAMANIAN AZODI, FARID AZIZI JALILIAN, and SOHEILA KHODAKARIM, “BIOMARKER PROFILING (ERBB2, P53, AND PR) FOR STAGE I OF BREAST CANCER,” ARCHIVES OF ADVANCES IN BIOSCIENCES (JOURNAL OF PARAMEDICAL SCIENCES), vol. 4, no. 4, pp. 47–50, 2013, [Online]. Available: https://sid.ir/paper/315822/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops